• Ahmed et al. (2026). CRL2FEM1B uses heme to recruit BACH1 for degradation and regulate ferroptosis in lung cancer. Mol Cell. doi: 10.1016/j.molcel.2026.04.008
  • Bost et al. (2026). Targeting Nipah virus replication: A fluorescence polarization assay for high-throughput modulators screening against the NTAIL-XD interaction. J Biol Chem. 302: 111382. doi: 10.1016/j.jbc.2026.111382
  • Storder et al. (2025). Engineering SIRPα conformational plasticity to reveal a cryptic pocket suitable for structure-based drug design. bioRxiv [Preprint]. 2025.12.10.693509. doi: 10.64898/2025.12.10.693509
  • Baksheeva et al. (2025). NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure-Activity Insights. J Med Chem. 68: 17485–17498. doi: 10.1021/acs.jmedchem.5c01008
  • Cuny et al. (2024). Cinacalcet reverses short QT interval in Familial Hypocalciuric Hypercalcemia type 1. J Clin Endocrinol Metab. 109: 549–556.
  • Desaunay et al. (2024). The Recurrent Liver MAN2A1-FER Oncoprotein Lacks Kinase Activity: Implications for the Use of Tyrosine Kinase Inhibitors. Cell Mol Gastroenterol Hepatol. 17: 667–669.
  • Hoffer et al. (2024). ChemoDOTS: a web server to design chemistry-driven focused libraries. Nucleic Acids Res. 52: W461–W468. doi: 10.1093/nar/gkae326
  • Ariey-Bonnet et al. (2023). Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms. EBioMedicine. 95: 104752. doi: 10.1016/j.ebiom.2023.104752
  • Saez-Ayala et al. (2023). From drug repositioning to structure-based design for acute lymphoblastic leukemia. Nat Commun. 14: 3079. doi: 10.1038/s41467-023-38668-2
  • Carrasco et al. (2022). CRCM5484: A BET-BDII selective compound with differential anti-leukemic drug modulation. J Med Chem. 65: 5660–5674. doi: 10.1021/acs.jmedchem.1c02168
  • Ganier et al. (2022). Small-molecule inhibitors of PTK7/β-Catenin interaction in colorectal cancer. ACS Chem Biol. 17: 1061–1072. doi: 10.1021/acschembio.1c00826
  • Garcia et al. (2021). Fragment-based design targeting syntenin PDZ2 domain. Eur J Med Chem. 223: 113601. doi: 10.1016/j.ejmech.2021.113601